After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology By: MarketWatch June 28, 2023 at 15:40 PM EDT Roivant shares gain more than 10% after narrower-than-expected quarterly loss. Read More >> Related Stocks: Argenx Se ADR Merck & Co Pfizer Roivant Sciences Ltd Teva Pharmaceutical Industries ADR
